**Executive Summary**
This report highlights the growth of India’s bioeconomy, which expanded from $10 billion in 2014 to over $195 billion in 2025. Released during the 14th Foundation Day of BIRAC on March 19, 2026, the document outlines a roadmap to reach a $300 billion target by 2030. Key action items include the implementation of the BioE3 Policy and the utilization of a ₹1 lakh crore Research, Development, and Innovation (RDI) Fund.
**Key Points / Main Content**
**Economic Growth and Scale**
* India's bioeconomy has achieved a valuation of $195.3 billion in 2025, reflecting an annual growth rate of 17–18%.
* The sector currently contributes approximately 4.8% to the national GDP.
* The government has set a strategic target to reach a $300 billion bioeconomy by 2030.
**Policy and Strategic Initiatives**
* The BioE3 Policy (Biotechnology for Economy, Environment, and Employment) has been introduced to drive sustainable biomanufacturing.
* The policy prioritizes innovation in precision biotherapeutics, smart proteins, climate-resilient agriculture, bio-based chemicals, and carbon capture.
* A ₹1 lakh crore RDI Fund has been established to provide long-term investment for biotechnology ventures and deep-tech scaling.
**Infrastructure and Innovation Ecosystem**
* BIRAC is facilitating the development of shared infrastructure, including bio-foundries, Bio-AI hubs, and advanced biomanufacturing platforms.
* The ecosystem is currently supported by over 11,800 biotech startups.
* There is a significant focus on nurturing talent in tier-2 and tier-3 cities, alongside support for women entrepreneurs and students.
**Report Releases**
* The India Bioeconomy Report (IBER) 2026 and the BIRAC Impact Report were officially released to document growth and measurable outcomes.
* The reports emphasize the success of targeted funding and mentorship in commercializing products and creating jobs.
**Impact Analysis**
**Biotech Startups and Entrepreneurs**
**Impact**
Startups benefit from an expanded ecosystem of 11,800+ peers and access to shared infrastructure like Bio-AI hubs and bio-foundries. The emphasis on tier-2 and tier-3 cities broadens the reach of innovation support.
**Action Required**
Startups should leverage BIRAC’s incubation and mentorship programs to transition ideas from laboratories to market-ready solutions.
**Scientists and Researchers**
**Impact**
Researchers gain access to the ₹1 lakh crore RDI Fund, which is designed to support long-term investment in deep-tech and technology translation.
**Action Required**
Focus research efforts on high-priority areas defined in the BioE3 policy, such as climate-resilient agriculture and precision biotherapeutics.
**Industry Representatives**
**Impact**
The BioE3 policy and RDI fund create opportunities for large-scale industrial growth and the development of sustainable biomanufacturing platforms.
**Action Required**
Collaborate with academia and government bodies to transform innovations into large-scale societal impact and commercial products.
**Policymakers and Government Enablers**
**Impact**
BIRAC and the Department of Biotechnology (DBT) are positioned as central enablers of a sector that contributes nearly 5% to the national GDP.
**Action Required**
Continue fostering industry-academia collaboration and ensure the effective disbursement of RDI funds to project-ready ventures.
Key Entities Referenced
BioE3 Policy: A policy focusing on Biotechnology for Economy, Environment and Employment, designed to strengthen bio-based industries and drive sustainable biomanufacturing in India.
Biotechnology Industry Research Assistance Council (BIRAC): An agency and key enabler of India’s biotechnology innovation ecosystem that supports startups and facilitates the transition of laboratory research into market-ready solutions.
Research, Development, and Innovation (RDI) Fund: A financial initiative with a ₹1 lakh crore outlay aimed at supporting biotechnology ventures and channeling long-term investment into deep-tech scale-up projects.
India Bioeconomy Report (IBER) 2026: A referenced report providing data on the growth of India’s bioeconomy, detailing its expansion to USD 195.3 billion and its 4.8 percent contribution to national GDP.
Ministry of Science & Technology
India’s Bioeconomy surges from $10 billion to
$195 billion in a decade, Registers 17–18%
Annual Growth: Dr Jitendra Singh
India Moving Towards $300 Billion Bioeconomy Target by
2030: Dr Jitendra Singh at BIRAC 14th Foundation Day Event
BioE3 Policy to Drive Sustainable Biomanufacturing as Over
11,800 Startups Power India’s Expanding Bioeconomy: Dr
Jitendra Singh
India Emerges as a Fast-Growing Biotech Innovation Hub,
with BioE3, RDI Push and Public Investment Driving Industrial
Growth and Jobs: Dr Jitendra Singh
India’s Bioeconomy Contributes Nearly 5% to GDP: IBER
2026 Report Released at BIRAC 14th Foundation Day Event
Posted On: 19 MAR 2026 2:16PM by PIB Delhi
Union Minister of State (Independent Charge) for Science & Technology, Earth Sciences, and MoS PMO,
Personnel, Public Grievances, Pensions, Atomic Energy and Space, Dr Jitendra Singh today said that
India’s bioeconomy has expanded from about USD 10 billion in 2014 to over USD 195 billion in 2025,
reflecting a massive growth trajectory over the past decade. He said the sector has recorded an annual
growth of around 17–18 percent in the last year alone, rising from approximately USD 165 billion to USD
195 billion, marking India’s emergence as a major global biotechnology hub.
Addressing the 14th Foundation Day celebrations of Biotechnology Industry Research Assistance Council
(BIRAC) at Civil Services Officers’ Institute, Chanakyapuri, New Delhi, Dr Jitendra Singh highlighted the
role of BIRAC as a key enabler of India’s biotechnology innovation ecosystem. The event was attended by
Dr Rajesh S. Gokhale, Secretary, Department of Biotechnology (DBT), Director General BRIC and
Chairman BIRAC; Prof Ashok Jhunjhunwala from IIT Madras; Dr Jitendra Kumar, Managing Director,
BIRAC; along with senior scientists, policymakers, industry representatives, and startup stakeholders.
The Union Minister said biotechnology is now central to India’s future growth story, driving
advancements in healthcare, agriculture, climate solutions, and sustainable manufacturing. He said that
India is steadily moving towards its target of a USD 300 billion bioeconomy by 2030, supported by astrong base of scientists, entrepreneurs, and startups. He added that BIRAC has played a crucial role in
connecting research with industry and enabling the transition of ideas from laboratories into market-ready
solutions.
Highlighting the government’s policy direction, Dr Jitendra Singh spoke about the BioE3 Policy,
Biotechnology for Economy, Environment and Employment, as a major step towards strengthening bio-
based industries and sustainable biomanufacturing. He said the policy will promote innovation in areas
such as precision biotherapeutics, smart proteins, climate-resilient agriculture, bio-based chemicals, and
carbon capture technologies. He added that BIRAC is facilitating this transformation by building shared
infrastructure such as bio foundries, Bio-AI hubs and advanced biomanufacturing platforms.
Referring to financial support mechanisms, the Minister spoke about the Research, Development, and
Innovation (RDI) Fund with an outlay of ₹1 lakh crore, under which BIRAC has been assigned a key role
in supporting biotechnology ventures. He said this initiative will help channel long-term investment into
projects ready for scale-up and technology translation, strengthening India’s deep-tech ecosystem.
During the event, the India Bioeconomy Report (IBER) 2026 and the BIRAC Impact Report were also
released. The reports highlight that India’s bioeconomy has reached USD 195.3 billion in 2025,
contributing around 4.8 percent to the national GDP, with a strong CAGR of nearly 18 percent. The sector
has more than doubled in size since 2020 and is supported by over 11,800 biotech startups across the
country.
The BIRAC Impact Report showcases how targeted funding, incubation and mentorship have enabled
industry-academia collaboration and led to the development of affordable healthcare solutions, sustainable
technologies, and job creation. It reflects measurable outcomes including commercialization of products,
expansion of startups and wider societal impact.
Dr Jitendra Singh emphasized the importance of nurturing young scientific talent, especially from tier-2
and tier-3 cities, and said that initiatives supporting students, researchers and women entrepreneurs are
helping build a nationwide culture of innovation.
Congratulating BIRAC on its 14th Foundation Day, he called for continued collaboration between science,
industry, and policymakers to transform innovation into large-scale impact and contribute to building a
self-reliant and developed India.*****
NKR/AK/MK(Release ID: 2242405) Visitor Counter : 310
Read this release in: Urdu , ही